Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
J Ayurveda Integr Med ; 3(1): 3-5, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22529672

ABSTRACT

Shilajit is a mineral-rich complex organic compound used in the traditional system of Ayurvedic medicine for treating hypertension and improving the cardiac function with many herbomineral preparations. However, very little experimental evidence is available about its effect on the cardiac function. We used Daphnia as a model organism for observing the effect of shilajit on its heart due to its myogenic properties and its response to number of cardioactive drugs that are known to affect human heart function. Genome of Daphnia shows the strongest homology with the human genome. These characteristics of Daphnia make it an ideal organism for biomedical research. Our results suggest that this complex organic compound lowers the heart beats as its concentration increases from 1.0 to 100 ppm. The beats come to near normal condition at 1000 ppm. Above 1000 ppm, the beats are very fast and impossible to count. These results indicate a negative chronotropic effect on the Daphnia heart at low concentrations and a positive chronotropic effect to arrhythmia and finally failure at increasing higher concentrations of shilajit.

2.
Indian J Surg Oncol ; 1(2): 146-50, 2010 Apr.
Article in English | MEDLINE | ID: mdl-22930629

ABSTRACT

Loss of voice is a major concern after total laryngectomy. Tracheo-esophageal prosthesis was described in 1980 by Blom and Singer as a method of postlaryngectomy voice rehabilitation. Since then it has seen many phases of developments. Now it has evolved into highly effective method with success rates more than 90% and better quality of voice than other modalities. It also gives good quality of life and voice related quality of life. Though it is associated with some complications, they are easy to manage. All these have made tracheo-esophageal prosthesis the 'Gold Standard' of post-laryngectomy voice rehabilitation.

3.
J Surg Oncol ; 100(5): 401-3, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19235784

ABSTRACT

BACKGROUND AND OBJECTIVES: PET-CT has shown promise in the management of head neck cancers. However, there have been only few studies evaluating its impact on management of patients with recurrent cancers in the presence of available clinicoradiologic methods of assessment. We conducted this study to assess the same in patients with suspected recurrent head and neck cancer. METHODS: Case histories were presented to two oncologists, who were blinded to PET-CT reports. Treatment plans were made by these oncologists based on clinical findings and other conventional imaging. These plans were then compared to the actual treatment received by patients after PET-CT. Any change was recorded as "change in management." RESULTS: Forty-nine patients with suspected recurrent head and neck cancer were evaluated in the study. Overall, there was a 38.7% change in management because of the addition of PET-CT to conventional methods of assessment. Eight patients (16.3%) had a major change in therapy while in 11 patients (22.4%), diagnostic procedures like endoscopies, biopsies and examination under anesthesia were avoided. CONCLUSION: In our study, PET-CT had a significant impact on the management of patients with suspected recurrent head neck cancer.


Subject(s)
Decision Making , Head and Neck Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Positron-Emission Tomography , Tomography, X-Ray Computed , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , False Negative Reactions , False Positive Reactions , Female , Head and Neck Neoplasms/therapy , Humans , Lymphatic Metastasis/diagnosis , Male , Middle Aged , Neck Dissection , Neoplasm Recurrence, Local/therapy , Palliative Care , Sensitivity and Specificity , Young Adult
4.
Indian J Cancer ; 44(4): 142-6, 2007.
Article in English | MEDLINE | ID: mdl-18322356

ABSTRACT

CONTEXT: Oral cancers represent a disparate group of tumors with diverse clinical behavior and chemosensitivity profile. Currently, it is difficult to predict whether a tumor will respond to chemotherapy and which drug(s) will achieve the maximum clinical response. AIMS: To study in vitro chemosensitivity profile of oral cancers and to correlate the in vitro chemosensitivity of oral cancer to clinical response to chemotherapy. SETTINGS AND DESIGN: Prospective study in a tertiary cancer care center. METHODS AND MATERIAL: We prospectively studied the chemosensitivity profile of 57 untreated, advanced, unresectable oral cancers to cisplatin, methotrexate, 5-fluorouracil and their combinations by using histoculture drug response assay (HDRA) and correlated them to the clinical response to chemotherapy. STATISTICAL ANALYSIS USED: Chi Square test. RESULTS: Biopsy samples were successfully histocultured in 52/57 (91%) cases. Of these 52 evaluable patients, 47 had primary gingivo-buccal cancers and five had tongue / floor of mouth cancers. Based on the assay, 27 (52%) tumors were sensitive to cisplatin, 27 (52%) to methotrexate, 24 (46%) to 5-fluorouracil, 38 (73%) to combination of cisplatin and methotrexate and 36 (69%) to combination of cisplatin and 5-fluorouracil. Of these, 31 patients with good performance status received two cycles of chemotherapy using one or more of these test drugs. There was a significant correlation (p=0.03) between the in vitro chemosensitivity and the clinical response. Negative predictive value of the test was 80%, positive predictive value-69%, sensitivity-79% and specificity -71%. The overall accuracy of the assay was 74%. CONCLUSIONS: We found HDRA to be a fairly good predictor of chemo-response of oral cancer.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Antimetabolites, Antineoplastic/pharmacology , Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Biological Assay , Cisplatin/pharmacology , Cisplatin/therapeutic use , Female , Fluorouracil/pharmacology , Fluorouracil/therapeutic use , Humans , In Vitro Techniques , Male , Methotrexate/pharmacology , Methotrexate/therapeutic use , Middle Aged , Prospective Studies , Treatment Outcome
5.
J Surg Oncol ; 93(1): 56-61, 2006 Jan 01.
Article in English | MEDLINE | ID: mdl-16353188

ABSTRACT

BACKGROUND: The management of patients with a small pharyngolaryngeal cancer (T1 and T2) with large nodal metastases is a subject of debate. We present data on the feasibility and outcome of treating these patients with surgery for the nodal metastases followed by definitive radiotherapy. METHODS: Prospective study of 59 patients of small pharyngolaryngeal primary squamous carcinomas with operable (N2/N3) nodal metastasis treated with neck dissection followed by radiotherapy. RESULTS: Complete nodal clearance was achieved in 54 (90%). The mean nodal size was 4 cm and extranodal extension was seen in 88% of patients in the study group. There were no significant postoperative complications. Median interval between surgery and radiotherapy was 23 days. Forty-nine patients (83%) started their RT within 6 weeks of surgery. With a median follow-up of 25 months, the disease free and overall survival was 54% and 60% (5 years). CONCLUSION: The management of patients with a radiocurable pharyngolaryngeal primary with large nodes by this approach is a feasible option with adequate control and survival.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Laryngeal Neoplasms/radiotherapy , Lymph Nodes/pathology , Lymphatic Irradiation , Neck Dissection , Pharyngeal Neoplasms/radiotherapy , Adult , Aged , Carcinoma, Squamous Cell/secondary , Carcinoma, Squamous Cell/surgery , Combined Modality Therapy , Disease-Free Survival , Feasibility Studies , Female , Humans , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/surgery , Lymphatic Metastasis , Male , Middle Aged , Neck , Neoplasm Staging , Pharyngeal Neoplasms/pathology , Pharyngeal Neoplasms/surgery , Prospective Studies , Treatment Outcome
6.
Infect Immun ; 73(9): 6179-82, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16113344

ABSTRACT

Previously, we identified bovine CD18 as the receptor for leukotoxin secreted by Mannheimia (Pasteurella) haemolytica. In this study, we constructed bovine-murine CD18 chimeras to locate the leukotoxin binding domain on CD18. Leukotoxin specifically lysed transfectants expressing bovine CD18 fragment encompassing amino acids 1 to 291, indicating that leukotoxin binding domain lies within amino acids 1 to 291 of bovine CD18.


Subject(s)
CD18 Antigens/genetics , CD18 Antigens/metabolism , Exotoxins/metabolism , Mannheimia haemolytica/metabolism , Recombinant Fusion Proteins/metabolism , Animals , CD18 Antigens/immunology , Cattle , Cell Line, Tumor , DNA, Complementary/genetics , DNA, Complementary/metabolism , Exotoxins/genetics , Mannheimia haemolytica/genetics , Mannheimia haemolytica/immunology , Mice , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Binding , Recombinant Fusion Proteins/genetics
7.
J Laryngol Otol ; 119(4): 303-5, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15949086

ABSTRACT

The pectoralis major myocutaneous (PMMC) flap is commonly used for head and neck reconstruction especially in impoverished nations. PMMC is a sturdy pedicled flap with relatively fewer complications, the learning curve is short and no specialized training in microvascular surgery is needed in order to use this flap. In a defect that requires a large skin and mucosal lining the authors routinely use either a bi-paddle PMMC or a combination of PMMC (for the mucosal lining) and a delto-pectoral flap (for the skin defect). It is indisputable that free tissue transfer is a better way of reconstruction for the majority of most such defects. Unfortunately, not all patients can be offered this form of reconstruction due to the cost, time, expertise and infrastructural constraints in high volume centres such as ours. Bi-paddling of PMMC is hazardous in obese males and most female patients. In such patients the skin defect is reconstructed usually by the delto-pectoral (DP) flap but this, for obvious reasons, is less welcomed by the patients. The authors suggest a technique wherein mucosal lining is created by the myofascial lining (inner surface) of the flap and the skin defect is reconstructed by the skin paddle of the single paddle PMMC. It should be considered wherever a DP flap is unacceptable, or bi-paddling or free tissue transfer is not possible.


Subject(s)
Head and Neck Neoplasms/surgery , Pectoralis Muscles/transplantation , Plastic Surgery Procedures/methods , Skin Transplantation/methods , Surgical Flaps , Female , Humans , Male , Mouth Mucosa/surgery
8.
J Cancer Res Ther ; 1(1): 51-6, 2005.
Article in English | MEDLINE | ID: mdl-17998627

ABSTRACT

Pharyngocutaneous (PC) fistula is a common complication following laryngectomy. It leads to increased morbidity, delay in adjuvant treatment, prolonged hospitalization and an increase in treatment costs. Although a number of factors that result in PC fistula have been described, there is still no agreement on the most significant factors. We undertook a prospective study to critically analyze PC fistula and its association with various tumors, patient and treatment related factors. This was a prospective study that included 143 patients who underwent laryngeal surgery for squamous cell carcinoma of the larynx and pyriform sinus. Use of pectoralis major myocutaneous flap to reconstruct the neopharynx, primary disease in pyriform and extensive soft tissue infiltration were significantly associated with PC fistula. Prior treatment (radiotherapy and chemotherapy), type of closure (T closure, Y closure and vertical closure), Layers of closure (full thickness interrupted, submucosal interrupted, submucosal continuous) type of suture material (silk, vicryl ), age, sex, stage, preoperative tracheostomy, cut margin status, pre/postoperative hemoglobin and experience of surgeons did not relate significantly.


Subject(s)
Fistula , Laryngectomy/adverse effects , Pharynx , Skin , Humans , Prospective Studies
9.
Indian J Cancer ; 42(4): 178-84, 2005.
Article in English | MEDLINE | ID: mdl-16391435

ABSTRACT

AIMS: To present the first cross-culture validation of the European organization for research and treatment of cancer (EORTC) quality of life questionnaires, the EORTC-QLQ-C30, and the QLQ-H&N 35 in India. SETTINGS AND DESIGN: These questionnaires were translated into two vernacular languages and pilot test was done on 15 patients. Two hundred head and neck cancer patients completed the QLQ-C30 and the QLQ-H&N 35 at two time points during their treatment. Psychometric evaluation of the structure, reliability, and validity of the questionnaire was undertaken. RESULTS: The data supports the reliability of the scales. Validity was tested by item-scale, scale--scale correlation and by performing known group comparisons. The results demonstrated that the items correlated with their respective scale and no significant correlation was found between scales. The questionnaire was responsive to change over a period of time. SUMMARY: This data suggests that the EORTC QLO-C30 and the QLQ-H&N 35 are reliable and valid questionnaires when applied to a sample of head and neck cancer patients in India.


Subject(s)
Guidelines as Topic , Head and Neck Neoplasms/psychology , Head and Neck Neoplasms/surgery , Quality of Life , Surveys and Questionnaires/standards , Combined Modality Therapy , Cross-Sectional Studies , Europe , Female , Head and Neck Neoplasms/epidemiology , Head and Neck Neoplasms/pathology , Humans , India , Longitudinal Studies , Male , Neck Dissection , Neoplasm Staging , Probability , Prospective Studies , Reproducibility of Results , Research/standards , Sickness Impact Profile , Statistics, Nonparametric
11.
Oral Oncol ; 40(9): 960-3, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15380176

ABSTRACT

Head and neck irradiation results in salivary dysfunction and subsequent xerostomia. Twenty two patients with squamous cancer of oropharynx or hypopharynx underwent contralateral submandibular salivary gland transfer (SMSGT) to submental triangle to shield it from subsequent radiotherapy. Resting salivary outputs of transferred and untransferred gland (control) were measured before and after SMSGT and following radiotherapy, by cannulating individual submandibular duct. They were compared by paired samples t-test. Following radiation therapy transferred gland retained 73% and untransferred gland (control) retained 27% of baseline salivary output. This significant difference in post-radiation salivary outputs suggests preservation of function of transferred salivary gland.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Pharyngeal Neoplasms/radiotherapy , Radiation Injuries/prevention & control , Submandibular Gland/transplantation , Female , Humans , Male , Prospective Studies , Radiation Injuries/etiology , Salivation/radiation effects , Submandibular Gland/metabolism , Submandibular Gland/radiation effects , Xerostomia/etiology , Xerostomia/prevention & control
12.
Eur J Surg Oncol ; 30(7): 804-6, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15296998

ABSTRACT

OBJECTIVE: To report a retrospective series of marginal mandibulectomy for cancers of oral cavity, with special reference to squamous cancers of gingival buccal complex. METHODS: Retrospective record review of 107 patients who underwent marginal mandibulectomy between 1994 and 2001. RESULTS: Eighty-three marginal mandibulectomies were done for gingivo-buccal complex cancers. Local failure rate was 16%. The 2-year and 5-year disease free survival rates were 69 and 60%, respectively. The local recurrence free survival at the end of 2 and 5 years were 79 and 70%, respectively. CONCLUSION: In carefully selected patients, marginal mandibulectomy is an oncologically safe procedure to achieve good local control.


Subject(s)
Carcinoma, Squamous Cell/surgery , Mandible/surgery , Mouth Neoplasms/surgery , Neoplasm Recurrence, Local/surgery , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Disease-Free Survival , Humans , India/epidemiology , Medical Records , Mouth Neoplasms/mortality , Mouth Neoplasms/pathology , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Retrospective Studies , Survival Analysis , Treatment Outcome
13.
Can J Urol ; 10(1): 1770-1, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12625859

ABSTRACT

Testicular metastasis presenting as a testicular mass is an extremely rare condition. There are only nine previously reported cases where testicular mass was the first clinical manifestation of underlying malignancy. Here we report a case of metastatic mucin secreting adenocarcinoma in testis presenting as a testicular mass with unknown primary. We have given a brief review of literature about the spread of tumor to testes.


Subject(s)
Adenocarcinoma, Mucinous/secondary , Neoplasms, Unknown Primary , Testicular Neoplasms/secondary , Fatal Outcome , Humans , Male , Middle Aged
14.
Infect Immun ; 70(9): 5058-64, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12183553

ABSTRACT

Leukotoxin (Lkt) secreted by Mannheimia (Pasteurella) haemolytica is an RTX toxin which is specific for ruminant leukocytes. Lkt binds to beta(2) integrins on the surface of bovine leukocytes. beta(2) integrins have a common beta subunit, CD18, that associates with three distinct alpha chains, CD11a, CD11b, and CD11c, to give rise to three different beta(2) integrins, CD11a/CD18 (LFA-1), CD11b/CD18 (Mac-1), and CD11c/CD18 (CR4), respectively. Our earlier studies revealed that Lkt binds to all three beta(2) integrins, suggesting that the common beta subunit, CD18, may be the receptor for Lkt. In order to unequivocally elucidate the role of bovine CD18 as a receptor for Lkt, a murine cell line nonsusceptible to Lkt (P815) was transfected with cDNA for bovine CD18. One of the transfectants, 2B2, stably expressed bovine CD18 on the cell surface. The 2B2 transfectant was effectively lysed by Lkt in a concentration-dependent manner, whereas the P815 parent cells were not. Immunoprecipitation of cell surface proteins of 2B2 with monoclonal antibodies specific for bovine CD18 or murine CD11a suggested that bovine CD18 was expressed on the cell surface of 2B2 as a heterodimer with murine CD11a. Expression of bovine CD18 and the Lkt-induced cytotoxicity of 2B2 cells were compared with those of bovine polymorphonuclear neutrophils and lymphocytes. There was a strong correlation between cell surface expression of bovine CD18 and percent cytotoxicity induced by Lkt. These results indicate that bovine CD18 is necessary and sufficient to mediate Lkt-induced cytolysis of target cells.


Subject(s)
CD18 Antigens/metabolism , Cytotoxicity, Immunologic , Exotoxins/immunology , Mannheimia haemolytica/immunology , Animals , Antibodies, Monoclonal/pharmacology , Base Sequence , CD18 Antigens/chemistry , CD18 Antigens/genetics , Cattle , Cell Line , DNA, Complementary/genetics , Dimerization , Lymphocyte Function-Associated Antigen-1/chemistry , Lymphocyte Function-Associated Antigen-1/genetics , Lymphocyte Function-Associated Antigen-1/metabolism , Mice , Neutralization Tests , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection
15.
Eur J Surg Oncol ; 27(7): 668-71, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11669596

ABSTRACT

INTRODUCTION: Percutaneous core biopsy of bone lesions provides early and definitive diagnosis and guides decisions on management. It is an inexpensive examination technique and has negligible complication rates. METHODS: We performed a prospective study of 136 patients who underwent core biopsies for bone lesions over an 18-month period. A Jamshidi (J) needle was used to obtain a core of tissue and specimens were sent for histopathological examination. Biopsy results were analysed for adequacy, ability to yield diagnostic information and for accuracy of diagnosis. RESULTS: The mean age of patients was 27.5 years with a range of 3-72 years. There were 84 males and 52 females in the study. Histopathological diagnosis was obtained in 121 (89%) patients. The specimen was non-diagnostic in 15 patients. Fourteen patients required two attempts and two patients required three attempts at biopsy. Sixty-two of 64 patients (96.9%) who had a confirmed final diagnosis had an accurate J-needle histopathological diagnosis. None of the patients had any major complications. DISCUSSION: Core needle biopsy is an important tool in the evaluation of bone lesions. It is a safe, reliable and accurate procedure and yields diagnostic information in a high proportion of patients. It has several advantages over an open bone biopsy.


Subject(s)
Biopsy, Needle/methods , Bone Neoplasms/pathology , Adolescent , Adult , Aged , Biopsy, Needle/instrumentation , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies
16.
Bioorg Med Chem Lett ; 11(17): 2393-6, 2001 Sep 03.
Article in English | MEDLINE | ID: mdl-11527739

ABSTRACT

Structure-activity studies associated with the salicylic acid-derived inhibitor of influenza fusion, BMY-27709, were examined using a parallel synthesis approach. This SAR survey led to the discovery of potent influenza inhibitory activity in a series of aromatic amides and thioamides derived from 1,3,3-trimethyl-5-hydroxycyclohexylmethylamine. Select compounds were characterized as inhibitors of the H1 subtype of influenza A viruses that act by preventing the pH-induced fusion process, thereby blocking viral entry into host cells. In a plaque-reduction assay, the most potent inhibitors displayed EC(50) values of 0.02-0.14 microg/mL.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Influenza A virus/drug effects , Thioamides/chemistry , Thioamides/pharmacology , Amines/chemistry , Cells, Cultured/virology , Drug Evaluation, Preclinical , Hemolysis/drug effects , Humans , Influenza A virus/pathogenicity , Magnetic Resonance Spectroscopy , Membrane Fusion/drug effects , Molecular Structure , Quinolizines/chemistry , Quinolizines/pharmacology , Stereoisomerism , Structure-Activity Relationship
17.
Vaccine ; 19(11-12): 1425-34, 2001 Jan 08.
Article in English | MEDLINE | ID: mdl-11163665

ABSTRACT

Epitope-based vaccines offer a promising alternative to modified live vaccines against viruses such as herpesviruses which give rise to latent infections, and induce immunosuppression. The success of this approach depends on the ability to direct the CTL epitopes to the MHC class I antigen presentation pathway. The objective of this study was to evaluate the potential of the heat shock protein gp96 in this regard. A group of BALB/c mice was injected with three murine CTL epitope peptides of bovine herpesvirus 1 (BHV-1) complexed in vitro with bovine gp96 (gp96-peptides). Three other groups were injected with either the peptides alone, gp96 alone, or the peptides complexed with BSA. CTLs from mice immunized with gp96-peptides specifically lysed the peptide-pulsed syngeneic targets, as well as BHV-1-infected targets. CTLs from the other three groups did not lyse these targets. To further evaluate the utility of this approach, groups of BALB/c mice were immunized with gp96 isolated from a syngeneic cell-line transduced with BHV-1 glycoprotein D (BC-gD). Mice immunized with gp96 from BC-gD developed CTLs, as well as Abs specific for BHV-1 gD. Furthermore, in vitro stimulation of naive bovine PBMCs with gp96 from BC-gD resulted in CTLs specific for BHV-1. These results demonstrate the feasibility of using gp96-peptide complexes isolated from cells expressing BHV-1 proteins to induce CTL and Ab responses against BHV-1, without the prior knowledge of the CTL and Ab epitope sequences.


Subject(s)
Antibodies, Viral/biosynthesis , Antigens, Neoplasm/immunology , HSP90 Heat-Shock Proteins/immunology , Herpesvirus 1, Bovine/immunology , T-Lymphocytes, Cytotoxic/immunology , Amino Acid Sequence , Animals , Antigens, Neoplasm/genetics , Antigens, Viral/genetics , Cattle , Epitopes/genetics , Female , H-2 Antigens/metabolism , HSP90 Heat-Shock Proteins/genetics , Herpesvirus 1, Bovine/genetics , In Vitro Techniques , Mice , Mice, Inbred BALB C , Viral Proteins/genetics , Viral Proteins/immunology
18.
Bioorg Med Chem Lett ; 10(8): 715-7, 2000 Apr 17.
Article in English | MEDLINE | ID: mdl-10782671

ABSTRACT

4-Thiazolidinones were synthesized and evaluated for their ability to inhibit the bacterial enzyme MurB. Selected 4-thiazolidinones displayed activity against the enzyme in vitro. This activity, coupled with the design principles of the thiazolidinones, supports the postulate that 4-thiazolidinones may be recognized as diphosphate mimics by a biological selector.


Subject(s)
Bacteria/enzymology , Carbohydrate Dehydrogenases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Thiazoles/pharmacology
19.
Comb Chem High Throughput Screen ; 2(4): 191-210, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10469880

ABSTRACT

Phage display is a biological system which facilitates the cloning and rapid selection of peptides from large combinatorial libraries. In compa-rison to the chemical combinatorial approach, the advantages of phage display lie in its simplicity and replicability. While phage display has many diverse applications, this review will focus on the use of phage peptide libraries to discover epitopes recognised by monoclonal antibodies. As monoclonal antibodies are useful tools for the detection of proteins and for the investigation of molecular interactions, the identification of their epitopes will serve to elucidate the structure and function of proteins, as well as aid in the discovery of new drugs and the development of vaccines.


Subject(s)
Heterocyclic Compounds/chemical synthesis , Pharmaceutical Preparations/chemical synthesis , Drug Design , Heterocyclic Compounds/chemistry , Indicators and Reagents , Molecular Structure , Pharmaceutical Preparations/chemistry
20.
Comb Chem High Throughput Screen ; 2(1): 29-32, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10420973

ABSTRACT

A novel protocol which employs commercially available, standard tools and hardware has been developed. This protocol allows for cleavage and collection of IRORI Microkan products in 96 well plate format. Typically, 640 compounds can be cleaved in a 4 hour time period using approximately 3 square feet of space. This protocol has been used successfully for the liberation of thousands of individual compounds, in single compound per well format from the solid phase. Additionally, this protocol is the first example of making IRORI Microkan technology directly compatible with standard 96 position deep well blocks.


Subject(s)
Equipment and Supplies , Peptide Library , Hydrolysis
SELECTION OF CITATIONS
SEARCH DETAIL
...